{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T09:50:06Z","timestamp":1792403406498,"version":"4.4.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010903","name":"Key Programme","doi-asserted-by":"publisher","award":["82230039"],"award-info":[{"award-number":["82230039"]}],"id":[{"id":"10.13039\/501100010903","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U21A20360"],"award-info":[{"award-number":["U21A20360"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017357","name":"Science and Technology Projects of Fujian Province","doi-asserted-by":"publisher","award":["2021Y9128"],"award-info":[{"award-number":["2021Y9128"]}],"id":[{"id":"10.13039\/100017357","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Spinocerebellar ataxia type 3 (SCA3) is a hereditary disease caused by abnormally expanded CAG repeats in the\n                      <jats:italic>ATXN3<\/jats:italic>\n                      gene. The study aimed to identify potential biomarkers for assessing therapeutic efficacy by investigating the associations between expanded CAG repeat size, brain and spinal cord volume loss, and motor functions in patients with SCA3.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this prospective, cross-observational study, we analyzed 3D T1-weighted MRIs from 92 patients with SCA3 and 42 healthy controls using voxel-based morphometry and region of interest approaches. Associations between expanded CAG repeat size, brain and spinal cord volume loss, and International Cooperative Ataxia Rating Scale (ICARS) scores were investigated using partial correlation and mediation analyses. Sample sizes of potential biomarkers were calculated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Compared with healthy controls, SCA3 patients had lower cerebellar volume and cervical spinal cord area. SCA3 patients evolved along a stage-independent decline that began in the cerebellum, progressed to spinal cord, brainstem, thalami, and basal ganglia, and extensive subcortex. Expanded CAG repeat size was associated with right cerebellar lobule IV volume (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u2009\u2212\u20090.423,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) and cervical spinal cord area (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u2009\u2212\u20090.405,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001), and higher ICARS (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.416,\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001). Mediation analysis revealed an indirect effect of expanded CAG repeat size on ICARS through spinal cord. Sample sizes estimation revealed that a minimum sample size was achieved with spinal cord measures.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results indicate the potential of cervical spinal cord area as a biomarker for disease progression and a minimum sample size estimation in future clinical studies of SCA3.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-025-03531-8","type":"journal-article","created":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T09:38:01Z","timestamp":1737625081000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Associations between CAG repeat size, brain and spinal cord volume loss, and motor symptoms in spinocerebellar ataxia type 3: a cohort study"],"prefix":"10.1186","volume":"20","author":[{"given":"Zhi-Xian","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Cheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Sen","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru-Ying","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Ting","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Ping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Jin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7552-5141","authenticated-orcid":false,"given":"Shi-Rui","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the OSCCAR Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,23]]},"reference":[{"issue":"4","key":"3531_CR1","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/ana.410390411","volume":"39","author":"A Durr","year":"1996","unstructured":"Durr A, Stevanin G, Cancel G, Duyckaerts C, Abbas N, Didierjean O, et al. Spinocerebellar ataxia 3 and Machado-Joseph disease: clinical, molecular, and neuropathological features. Ann Neurol. 1996;39(4):490\u20139. https:\/\/doi.org\/10.1002\/ana.410390411.","journal-title":"Ann Neurol"},{"issue":"1","key":"3531_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41572-019-0074-3","volume":"5","author":"T Klockgether","year":"2019","unstructured":"Klockgether T, Mariotti C, Paulson HL. Spinocerebellar ataxia. Nat Rev Dis Primers. 2019;5(1):24. https:\/\/doi.org\/10.1038\/s41572-019-0074-3.","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"3531_CR3","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s13311-019-00798-1","volume":"16","author":"JD Da Silva","year":"2019","unstructured":"Da Silva JD, Teixeira-Castro A, Maciel P. From pathogenesis to novel therapeutics for spinocerebellar ataxia type 3: evading potholes on the way to translation. Neurotherapeutics. 2019;16(4):1009\u201331. https:\/\/doi.org\/10.1007\/s13311-019-00798-1.","journal-title":"Neurotherapeutics"},{"key":"3531_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-12042-0","author":"ZX Ye","year":"2023","unstructured":"Ye ZX, Bi J, Qiu LL, Chen XY, Li MC, Chen XY, et al. Cognitive impairment associated with cerebellar volume loss in spinocerebellar ataxia type 3. J Neurol. 2023. https:\/\/doi.org\/10.1007\/s00415-023-12042-0.","journal-title":"J Neurol"},{"key":"3531_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/ene.12559","author":"TJ de Rezende","year":"2015","unstructured":"de Rezende TJ, D\u2019Abreu A, Guimaraes RP, Lopes TM, Lopes-Cendes I, Cendes F, et al. Cerebral cortex involvement in Machado-Joseph disease. Eur J Neurol. 2015. https:\/\/doi.org\/10.1111\/ene.12559.","journal-title":"Eur J Neurol."},{"issue":"2","key":"3531_CR6","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1007\/s12311-014-0619-7","volume":"14","author":"CN Fahl","year":"2015","unstructured":"Fahl CN, Branco LM, Bergo FP, D\u2019Abreu A, Lopes-Cendes I, Fran\u00e7a MC Jr. Spinal cord damage in Machado-Joseph disease. Cerebellum. 2015;14(2):128\u201332. https:\/\/doi.org\/10.1007\/s12311-014-0619-7.","journal-title":"Cerebellum"},{"issue":"3","key":"3531_CR7","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/ana.25297","volume":"84","author":"TJR Rezende","year":"2018","unstructured":"Rezende TJR, de Paiva JLR, Martinez ARM, Lopes-Cendes I, Pedroso JL, Barsottini OGP, et al. Structural signature of SCA3: From presymptomatic to late disease stages. Ann Neurol. 2018;84(3):401\u20138. https:\/\/doi.org\/10.1002\/ana.25297.","journal-title":"Ann Neurol"},{"issue":"22","key":"3531_CR8","doi-asserted-by":"publisher","first-page":"e3036","DOI":"10.1212\/wnl.0000000000010986","volume":"95","author":"J Guo","year":"2020","unstructured":"Guo J, Chen H, Biswal BB, Guo X, Zhang H, Dai L, et al. Gray matter atrophy patterns within the cerebellum-neostriatum-cortical network in SCA3. Neurology. 2020;95(22):e3036\u201344. https:\/\/doi.org\/10.1212\/wnl.0000000000010986.","journal-title":"Neurology"},{"issue":"10","key":"3531_CR9","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1002\/mds.28610","volume":"36","author":"J Faber","year":"2021","unstructured":"Faber J, Schaprian T, Berkan K, Reetz K, Fran\u00e7a MC Jr, de Rezende TJR, et al. Regional brain and spinal cord volume loss in spinocerebellar ataxia type 3. Mov Disord. 2021;36(10):2273\u201381. https:\/\/doi.org\/10.1002\/mds.28610.","journal-title":"Mov Disord"},{"issue":"11","key":"3531_CR10","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/s1474-4422(15)00202-1","volume":"14","author":"H Jacobi","year":"2015","unstructured":"Jacobi H, du Montcel ST, Bauer P, Giunti P, Cook A, Labrum R, et al. Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study. Lancet Neurol. 2015;14(11):1101\u20138. https:\/\/doi.org\/10.1016\/s1474-4422(15)00202-1.","journal-title":"Lancet Neurol"},{"issue":"1","key":"3531_CR11","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/ana.25919","volume":"89","author":"VB Leotti","year":"2021","unstructured":"Leotti VB, de Vries JJ, Oliveira CM, de Mattos EP, Te Meerman GJ, Brunt ER, et al. CAG repeat size influences the progression rate of spinocerebellar ataxia type 3. Ann Neurol. 2021;89(1):66\u201373. https:\/\/doi.org\/10.1002\/ana.25919.","journal-title":"Ann Neurol"},{"issue":"4","key":"3531_CR12","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s13311-022-01231-w","volume":"19","author":"R Maas","year":"2022","unstructured":"Maas R, Teerenstra S, Toni I, Klockgether T, Schutter D, van de Warrenburg BPC. Cerebellar transcranial direct current stimulation in spinocerebellar ataxia type 3: a randomized, double-blind. Sham-Controlled Trial Neurotherapeutics. 2022;19(4):1259\u201372. https:\/\/doi.org\/10.1007\/s13311-022-01231-w.","journal-title":"Sham-Controlled Trial Neurotherapeutics"},{"key":"3531_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2022.105236","volume":"106","author":"A Sikandar","year":"2023","unstructured":"Sikandar A, Liu XH, Xu HL, Li Y, Lin YQ, Chen XY, et al. Short-term efficacy of repetitive transcranial magnetic stimulation in SCA3: a prospective, randomized, double-blind, sham-controlled study. Parkinsonism Relat Disord. 2023;106: 105236. https:\/\/doi.org\/10.1016\/j.parkreldis.2022.105236.","journal-title":"Parkinsonism Relat Disord"},{"issue":"11","key":"3531_CR14","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1212\/01.wnl.0000219042.60538.92","volume":"66","author":"T Schmitz-Hubsch","year":"2006","unstructured":"Schmitz-Hubsch T, du Montcel ST, Baliko L, Berciano J, Boesch S, Depondt C, et al. Scale for the assessment and rating of ataxia: development of a new clinical scale. Neurology. 2006;66(11):1717\u201320. https:\/\/doi.org\/10.1212\/01.wnl.0000219042.60538.92.","journal-title":"Neurology"},{"key":"3531_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-510x(96)00231-6","author":"P Trouillas","year":"1997","unstructured":"Trouillas P, Takayanagi T, Hallett M, Currier RD, Subramony SH, Wessel K, et al. International cooperative ataxia rating scale for pharmacological assessment of the cerebellar syndrome. The ataxia neuropharmacology committee of the World federation of neurology. J Neurol Sci. 1997. https:\/\/doi.org\/10.1016\/s0022-510x(96)00231-6.","journal-title":"J Neurol Sci."},{"issue":"1","key":"3531_CR16","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1212\/wnl.0000000000001711","volume":"85","author":"RP Maas","year":"2015","unstructured":"Maas RP, van Gaalen J, Klockgether T, van de Warrenburg BP. The preclinical stage of spinocerebellar ataxias. Neurology. 2015;85(1):96\u2013103. https:\/\/doi.org\/10.1212\/wnl.0000000000001711.","journal-title":"Neurology"},{"issue":"14","key":"3531_CR17","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1177\/1352458514533399","volume":"20","author":"M Daams","year":"2014","unstructured":"Daams M, Weiler F, Steenwijk MD, Hahn HK, Geurts JJ, Vrenken H, et al. Mean upper cervical cord area (MUCCA) measurement in long-standing multiple sclerosis: relation to brain findings and clinical disability. Mult Scler. 2014;20(14):1860\u20135. https:\/\/doi.org\/10.1177\/1352458514533399.","journal-title":"Mult Scler"},{"key":"3531_CR18","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/j.neuroimage.2016.11.003","volume":"147","author":"JE Romero","year":"2017","unstructured":"Romero JE, Coup\u00e9 P, Giraud R, Ta VT, Fonov V, Park MTM, et al. CERES: a new cerebellum lobule segmentation method. Neuroimage. 2017;147:916\u201324. https:\/\/doi.org\/10.1016\/j.neuroimage.2016.11.003.","journal-title":"Neuroimage"},{"issue":"Pt 5","key":"3531_CR19","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1093\/brain\/119.5.1497","volume":"119","author":"K B\u00fcrk","year":"1996","unstructured":"B\u00fcrk K, Abele M, Fetter M, Dichgans J, Skalej M, Laccone F, et al. Autosomal dominant cerebellar ataxia type I clinical features and MRI in families with SCA1, SCA2 and SCA3. Brain. 1996;119(Pt 5):1497\u2013505. https:\/\/doi.org\/10.1093\/brain\/119.5.1497.","journal-title":"Brain"},{"issue":"1","key":"3531_CR20","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.neuroimage.2009.07.027","volume":"49","author":"JB Schulz","year":"2010","unstructured":"Schulz JB, Borkert J, Wolf S, Schmitz-H\u00fcbsch T, Rakowicz M, Mariotti C, et al. Visualization, quantification and correlation of brain atrophy with clinical symptoms in spinocerebellar ataxia types 1, 3 and 6. Neuroimage. 2010;49(1):158\u201368. https:\/\/doi.org\/10.1016\/j.neuroimage.2009.07.027.","journal-title":"Neuroimage"},{"issue":"1","key":"3531_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-012-1000-x","volume":"124","author":"K Seidel","year":"2012","unstructured":"Seidel K, Siswanto S, Brunt ER, den Dunnen W, Korf HW, R\u00fcb U. Brain pathology of spinocerebellar ataxias. Acta Neuropathol. 2012;124(1):1\u201321. https:\/\/doi.org\/10.1007\/s00401-012-1000-x.","journal-title":"Acta Neuropathol"},{"key":"3531_CR22","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/978-3-319-71779-1_11","volume":"1049","author":"AH Koeppen","year":"2018","unstructured":"Koeppen AH. the neuropathology of spinocerebellar ataxia type 3\/Machado-joseph disease. Adv Exp Med Biol. 2018;1049:233\u201341. https:\/\/doi.org\/10.1007\/978-3-319-71779-1_11.","journal-title":"Adv Exp Med Biol"},{"issue":"8","key":"3531_CR23","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1002\/mds.25451","volume":"28","author":"RP Guimar\u00e3es","year":"2013","unstructured":"Guimar\u00e3es RP, D\u2019Abreu A, Yasuda CL, Fran\u00e7a MC Jr, Silva BH, Cappabianco FA, et al. A multimodal evaluation of microstructural white matter damage in spinocerebellar ataxia type 3. Mov Disord. 2013;28(8):1125\u201332. https:\/\/doi.org\/10.1002\/mds.25451.","journal-title":"Mov Disord"},{"issue":"9","key":"3531_CR24","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/s1474-4422(09)70170-x","volume":"8","author":"SJ Tabrizi","year":"2009","unstructured":"Tabrizi SJ, Langbehn DR, Leavitt BR, Roos RA, Durr A, Craufurd D, et al. Biological and clinical manifestations of Huntington\u2019s disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol. 2009;8(9):791\u2013801. https:\/\/doi.org\/10.1016\/s1474-4422(09)70170-x.","journal-title":"Lancet Neurol"},{"key":"3531_CR25","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.nicl.2016.12.006","volume":"14","author":"SE Lee","year":"2017","unstructured":"Lee SE, Sias AC, Mandelli ML, Brown JA, Brown AB, Khazenzon AM, et al. Network degeneration and dysfunction in presymptomatic C9ORF72 expansion carriers. Neuroimage Clin. 2017;14:286\u201397. https:\/\/doi.org\/10.1016\/j.nicl.2016.12.006.","journal-title":"Neuroimage Clin"},{"issue":"4","key":"3531_CR26","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1007\/s00330-022-09214-3","volume":"33","author":"H Qiu","year":"2023","unstructured":"Qiu H, Wu C, Liang J, Hu M, Chen Y, Huang Z, et al. Structural alterations of spinocerebellar ataxias type 3: from pre-symptomatic to symptomatic stage. Eur Radiol. 2023;33(4):2881\u201394. https:\/\/doi.org\/10.1007\/s00330-022-09214-3.","journal-title":"Eur Radiol"},{"key":"3531_CR27","doi-asserted-by":"publisher","DOI":"10.1002\/ana.26824","author":"J Faber","year":"2023","unstructured":"Faber J, Berger M, Wilke C, Hubener-Schmid J, Schaprian T, Santana MM, et al. Stage-dependent biomarker changes in spinocerebellar ataxia type 3. Ann Neurol. 2023. https:\/\/doi.org\/10.1002\/ana.26824.","journal-title":"Ann Neurol"},{"issue":"4","key":"3531_CR28","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/bf00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991;82(4):239\u201359. https:\/\/doi.org\/10.1007\/bf00308809.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"3531_CR29","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/s0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak H, Del Tredici K, R\u00fcb U, de Vos RA, Jansen Steur EN, Braak E. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol Aging. 2003;24(2):197\u2013211. https:\/\/doi.org\/10.1016\/s0197-4580(02)00065-9.","journal-title":"Neurobiol Aging"},{"issue":"3","key":"3531_CR30","doi-asserted-by":"publisher","first-page":"e460","DOI":"10.1212\/wnl.0000000000011155","volume":"96","author":"N Pyatigorskaya","year":"2021","unstructured":"Pyatigorskaya N, Yahia-Cherif L, Valabregue R, Gaurav R, Gargouri F, Ewenczyk C, et al. Parkinson disease propagation using mri biomarkers and partial least squares path modeling. Neurology. 2021;96(3):e460\u201371. https:\/\/doi.org\/10.1212\/wnl.0000000000011155.","journal-title":"Neurology"},{"issue":"9","key":"3531_CR31","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1038\/s41591-021-01456-w","volume":"27","author":"TA Pascoal","year":"2021","unstructured":"Pascoal TA, Benedet AL, Ashton NJ, Kang MS, Therriault J, Chamoun M, et al. Microglial activation and tau propagate jointly across Braak stages. Nat Med. 2021;27(9):1592\u20139. https:\/\/doi.org\/10.1038\/s41591-021-01456-w.","journal-title":"Nat Med"},{"issue":"1","key":"3531_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00702-020-02271-2","volume":"128","author":"A Martin-Bastida","year":"2021","unstructured":"Martin-Bastida A, Tilley BS, Bansal S, Gentleman SM, Dexter DT, Ward RJ. Iron and inflammation: in vivo and post-mortem studies in Parkinson\u2019s disease. J Neural Transm (Vienna). 2021;128(1):15\u201325. https:\/\/doi.org\/10.1007\/s00702-020-02271-2.","journal-title":"J Neural Transm (Vienna)"},{"issue":"15","key":"3531_CR33","doi-asserted-by":"publisher","first-page":"5389","DOI":"10.1523\/jneurosci.21-15-05389.2001","volume":"21","author":"BO Evert","year":"2001","unstructured":"Evert BO, Vogt IR, Kindermann C, Ozimek L, de Vos RA, Brunt ER, et al. Inflammatory genes are upregulated in expanded ataxin-3-expressing cell lines and spinocerebellar ataxia type 3 brains. J Neurosci. 2001;21(15):5389\u201396. https:\/\/doi.org\/10.1523\/jneurosci.21-15-05389.2001.","journal-title":"J Neurosci"},{"issue":"23","key":"3531_CR34","doi-asserted-by":"publisher","first-page":"23619","DOI":"10.18632\/aging.103700","volume":"12","author":"YJ Chiu","year":"2020","unstructured":"Chiu YJ, Lin SA, Chen WL, Lin TH, Lin CH, Yao CF, et al. Pathomechanism characterization and potential therapeutics identification for SCA3 targeting neuroinflammation. Aging (Albany NY). 2020;12(23):23619\u201346. https:\/\/doi.org\/10.18632\/aging.103700.","journal-title":"Aging (Albany NY)"},{"issue":"7","key":"3531_CR35","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1002\/mds.29029","volume":"37","author":"J Guo","year":"2022","unstructured":"Guo J, Jiang Z, Biswal BB, Zhou B, Xie D, Gao Q, et al. Hypothalamic atrophy, expanded CAG repeat, and low body mass index in spinocerebellar ataxia type 3. Mov Disord. 2022;37(7):1541\u20136. https:\/\/doi.org\/10.1002\/mds.29029.","journal-title":"Mov Disord"},{"key":"3531_CR36","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.nicl.2016.11.007","volume":"13","author":"SR Huang","year":"2017","unstructured":"Huang SR, Wu YT, Jao CW, Soong BW, Lirng JF, Wu HM, et al. CAG repeat length does not associate with the rate of cerebellar degeneration in spinocerebellar ataxia type 3. Neuroimage Clin. 2017;13:97\u2013105. https:\/\/doi.org\/10.1016\/j.nicl.2016.11.007.","journal-title":"Neuroimage Clin"},{"issue":"4","key":"3531_CR37","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s00401-010-0699-5","volume":"120","author":"H Shimizu","year":"2010","unstructured":"Shimizu H, Yamada M, Toyoshima Y, Ikeuchi T, Onodera O, Takahashi H. Involvement of Onuf\u2019s nucleus in Machado-Joseph disease: a morphometric and immunohistochemical study. Acta Neuropathol. 2010;120(4):439\u201348. https:\/\/doi.org\/10.1007\/s00401-010-0699-5.","journal-title":"Acta Neuropathol"},{"issue":"3","key":"3531_CR38","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s12311-010-0179-4","volume":"9","author":"LB Jardim","year":"2010","unstructured":"Jardim LB, Hauser L, Kieling C, Saute JA, Xavier R, Rieder CR, et al. Progression rate of neurological deficits in a 10-year cohort of SCA3 patients. Cerebellum. 2010;9(3):419\u201328. https:\/\/doi.org\/10.1007\/s12311-010-0179-4.","journal-title":"Cerebellum"},{"issue":"11","key":"3531_CR39","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1002\/mds.23809","volume":"26","author":"YC Lee","year":"2011","unstructured":"Lee YC, Liao YC, Wang PS, Lee IH, Lin KP, Soong BW. Comparison of cerebellar ataxias: a three-year prospective longitudinal assessment. Mov Disord. 2011;26(11):2081\u20137. https:\/\/doi.org\/10.1002\/mds.23809.","journal-title":"Mov Disord"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03531-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03531-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03531-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T09:38:04Z","timestamp":1737625084000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03531-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,23]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3531"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03531-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4593982\/v1","asserted-by":"object"}]},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,23]]},"assertion":[{"value":"19 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"35"}}